These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7904939)

  • 21. Risks of initiating therapy with sotalol for treatment of atrial fibrillation.
    Marcus FI
    J Am Coll Cardiol; 1998 Jul; 32(1):177-80. PubMed ID: 9669267
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter.
    Gallik DM; Kim SG; Ferrick KJ; Roth JA; Fisher JD
    Am Heart J; 1997 Aug; 134(2 Pt 1):155-60. PubMed ID: 9313591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H; Schlepper M
    Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
    Mihálcz A; Földesi C; Kardos A; Ladunga K; Szili-Török T
    Orv Hetil; 2009 Sep; 150(36):1694-700. PubMed ID: 19709984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
    Gonska BD; Rab J
    Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of sotalol (Darob) therapy in supraventricular tachyarrhythmias.
    Toporan D; Protopopescu T; Ioan A; Paraschiv A
    Rom J Intern Med; 1998; 36(3-4):207-17. PubMed ID: 10822517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of supraventricular tachycardia.
    Shakespeare CF; Anderson M; Camm AJ
    Eur Heart J; 1993 Sep; 14 Suppl E():2-8. PubMed ID: 8223750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of atrial tachyarrhythmia in patients with Wolff-Parkinson-White syndrome with and without spontaneous atrial fibrillation].
    Gaita F; Giustetto C; Riccardi R; Mangiardi L; Brusca A
    G Ital Cardiol; 1990 Feb; 20(2):109-13. PubMed ID: 2328863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AV reciprocating tachycardia with intermittent bundle branch block in latent Wolff-Parkinson-White syndrome].
    Veress G
    Orv Hetil; 1994 May; 135(21):1131-6. PubMed ID: 7910681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
    Tuzcu EM; Gilbo J; Masterson M; Maloney JD
    Cleve Clin J Med; 1989 May; 56(3):238-42. PubMed ID: 2743545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological effects of sotalol--just another beta blocker?
    Nathan AW; Hellestrand KJ; Bexton RS; Ward DE; Spurrell RA; Camm AJ
    Br Heart J; 1982 Jun; 47(6):515-20. PubMed ID: 7082499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery for supraventricular tachyarrhythmias.
    Guiraudon GM; Klein J; Yee R
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1965-9. PubMed ID: 1763306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.
    Calkins H; Sousa J; el-Atassi R; Rosenheck S; de Buitleir M; Kou WH; Kadish AH; Langberg JJ; Morady F
    N Engl J Med; 1991 Jun; 324(23):1612-8. PubMed ID: 2030717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.